Brief: Nautilus Biotechnology Posts Q4 Loss Per Share Of 11 Cents
23/02/2023 11:12
Feb 23 (Reuters) - Nautilus Biotechnology Q4 net income USD -13.409 million. * Q4 operating expenses USD 16.304 million * Q4 EPS USD -0.11
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11